NCT03998267

Qatar Diabetes Mobile Application Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 180 (estimated)
• Sponsor: Hamad Medical Corporation · Industry
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

Diabetes mobile technology is an emerging and rapidly expanding field that seeks to combine cutting edge behavioral insights with best practice in diabetes self management education to improve patient empowerment and deliver better patient outcomes.The question that arises is whether or not, diabetes mobile applications are effective in improving glycemic control, clinical outcomes, quality of life and overall patient satisfaction, in diabetic patients in Qatar. To answer this, we plan to enroll 90 diabetic patients into a custom-made diabetes app for Qatar (Droobi) (as intervention group) in comparison with 90 diabetic patients followed in the current standard care, matched in characteristics (as control group). We have the hypothesis that with utilization of the mobile application, patients will have improved glycemic control, improved self management and patient empowerment; together with improved patient-educator/doctor interaction.

Conditions

• Type2 Diabetes Mellitus

Interventions

Type	Name	Description
DEVICE	Droobi	A new mobile application, specifically built for the diabetes patients in Qatar with the help of local expertise.
OTHER	Standard of care	Standard of care including physicians, dietetics and diabetes educators support

Timeline

• Start date: 2019-08-22
• Primary completion: 2020-08-17
• Completion: 2020-12-31
• First posted: 2019-06-26
• Last updated: 2020-02-17

Locations

1 site across 1 country: Qatar